Identification and expression of α cDNA encoding human 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (ACMSD): A key enzyme for the tryptophan-niacine pathway and quinolinate hypothesis

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 443-453

  Fukuoka, Shin Ichi ^a   Ishiguro, Kanako ^a   Tanabe, Atsushi ^b   Egashira, Yukari ^b   Sanada, Hiroo ^b   Fukuwatari, Tsutomu ^d   Shibata, Katsumi ^c  

^a KYOTO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF SHIGA PREFECTURE   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 CARBOXYMUCONATE 6 SEMIALDEHYDE DECARBOXYLASE; BRAIN ENZYME; COMPLEMENTARY DNA; ENZYME; EXCITOTOXIN; QUINOLINIC ACID; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CATABOLISM; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DOWN REGULATION; EVOLUTIONARY HOMOLOGY; GENETIC CODE; MALE; MAMMAL; MOLECULAR CLONING; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITION; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DIET; PROTEIN EXPRESSION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALIA; MAMMALIA; SUIDAE;

EID: 1042268011     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_52     Document Type: Conference Paper

References (25)

1. T. W. Stone and M. N. Perkins, Quinolinic acid: A potent endogenous excitant at amino acid receptor in CNS, Eur. J. Pharmacol. 72, 411-412 (1981).
2. M. N. Perkins and T. W. Stone, An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid, Brain Res. 247, 184-187 (1982).
3. M. N. Perkins, and T. W. Stone, Quinolinic acid: regional variations in neuronal sensitivity, Brain Res. 259, 172-176 (1983).
4. R. Schwarcz, W. O. Whetsell, and R. M. Mangano, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain, Science 219, 316-318 (1983).
5. R. Schwarcz, A. C. Foster, F. D. French, W. O. Jr. Whetsell, and C. Kohler, Excitotoxic models of neurodegenerative disorders, Life Sci. 35, 19-32 (1984).
6. M. F. Beal, N. W. Kowall, K. J. Swartz, R. J. Ferrante, and J. B. Martin, Systemic approaches to modifying quinolinic acid striatal lesions in rats, J. Neurosci. 8, 3901-3908 (1988).
7. A. B. Young, J. T. Greenamyre, Z. Hollingsworth, R. Albin, C. D'Amato, I. Shoulson, and J. B. Penney, NMDA receptor losses in putamen from patients with Huntington's disease, Science 241, 981-983 (1988).
8. R. Schwarcz, C. Speciale, E. Okuno, E. D. French, and C. Kohler, Excitatory Amino Acids and Epilepsy (Schwarcz, R. and Ari, Y., eds.) (Plenum Publishing Corporation, 1986), pp. 697-707.
9. R. Schwarcz, E. Okuno, C. Speciale, C. Kohler , and Jr. W. O. Whetsell, Neuronal degeneration in animals and man: the quinolinic acid connection, in: Neurotoxins and Their Pharmacological Implications, edited by P. Jenner (Raven Press, New York, 1987), pp. 19-32.
10. R. Schwarcz, E. Okuno, R. J. White, E. D. Bird and W. O. Whetsell, 3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims, Proc. Natl. Acad. Sci. USA 85, 4079-4081 (1988).
11. K. Shibata, Nutritional factors that regulate on the conversion of L-tryptophan to niacin, Adv. Exp. Med. Biol. 467, 711-716 (1999).
12. K. Shibata, T. Kondo, M. Marugami, and C. Umezawa, Increased conversion ratio of tryptophan 10 niacin by the administration of clofibrate, a hypolipidemic drug, to rats, Biosci. Biotechnol. Biochem. 60, 1455-1459 (1996).
13. K. Shibata, Effect of hormones on the conversion ratio of tryptophan to niacin, Vitamins (Japan), 72, 85-96 (1998).
14. S. Nasu, K. Yamaguchi, S. Sakakibara, H. Imai, and I. Ueda, The effect of pyrazines on the metabolism of tryptophan and nicotinamide adenine dinucleotide in the rat. Evidence of the formation of a potent inhibitor of aminocarboxy-muconate-semialdehyde decarboxylase from pyrazinamide, Biochem. Biophys. Acta, 677, 109-119 (1981).
15. H. Sanada, M. Miyazaki, and T. Takahashi, Regulation of tryptophan-niacin metabolism in diabetic rats. J. Nutr. Sci. Vitaminol. 26, 449-459 (1980).
16. S. Fukuoka, and G. A. Scheele, Rapid and selective cloning of monitor peptide, a novel cholecystokinin-releasing peptide, using minimal amino acid sequence and the polymerase chain reaction, Pancreas 5, 1-7 (1990).
17. Y. Egashira, H. Kouhashi, T. Ohta, and H. Sanada, Purification and properties of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD), key enzyme of niacin synthesis from tryptophan, from hog kidney, J. Nutr. Sci. Vitaminol. 42, 173-183 (1996).
18. R. H. Aebersold, J. Leavitt, R. A. Saavedra, L. E. Hood and S. B. Kent, Internal amino acid sequence analysis of proteins separated by one- or two-dimensional gel electrophoresis after in situ protease digestion on nitrocellulose, Proc. Natl. Acad. Sci. USA 84, 6970-6974 (1987).
19. S-I. Fukuoka, C. M. Nyaruhucha and K. Shibata, Characterization and functional expression of the cDNA encoding human brain quinolinate phosphoribosyltransferase, Biochim. Biophys. Acta 1395, 192-201 (1998).
20. S. F. Altschul, W. Gish, W. Miller, E. W. Myers, and D. J. Lipman, Basic local alignment search tool, J. Mol. Biol. 215, 403-10 (1990).
21. A. Ichiyama, S. Nakamura, H. Kawai, T. Honjo, Y. Nishizuka, O. Hayaishi, and S. Senoh, Studies on the metabolism of the benzene ring of tryptophan in mammalian tissues, J. Biol. Chem. 240, 740-749 (1965).
22. K. Shibata, and H. Matsuo, Effect of supplementing low protein diets with the limiting amino acids on the excretion of N1-methylnicotinamide and its pyridones in rats, J. Nutr. 119, 896-901 (1989).
23. T. Ikemura, and K. Wada, Evident diversity of codon usage patterns of human genes with respect to chromosome banding patterns and chromosome numbers; relation between nucleotide sequence data and cytogenetic data, Nucleic Acids Res. 19, 4333-4339 (1991).
24. Y. Nishizuka, A. Ichiyama and O. Hayaishi, II. Picolinic carboxylase (cat liver), (α-amino β-carboxymuconic-ε-semialdehyde β-decarboxylase) Methods Enzymol. 17A, 471-476 (1970).
25. A. C. Foster, L. P. Miller, W. H. Oldendorf, and R. Schwarcz, Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat, Exp. Neurol. 84, 428-440 (1984).